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The Creation of a Next-Generation Cancer Treatment Using
Photodynamic Therapy
Jasmine Baughman & Dr. Joseph E. Bradshaw
Ouachita Baptist University Department of Chemistry, Arkadelphia, AR 71998-0001
Photodynamic therapy (PDT) is a treatment for various health
disorders, including cancer, that uses a photosensitive agent
and light. Unlike other cancer treatments, PDT is a focused
treatment that kills cancerous cells without harming the
surrounding tissues. When a photosensitive agent is
administered, it accumulates in the tumor as it binds to low
density lipoproteins. When the tumor is exposed to a specific
wavelength of light, the photosensitive agent is activated;
this results in the release singlet oxygen, which kills the
tumor. The objective of this research was to synthesize and
characterize a novel photosensitive agent, H2TPP-2A2E.
Purification of the novel be used in the next generation of
photodynamic therapy. material was achieved using column
chromatography. In addition, IR, UV-vis, and NMR
spectroscopies were used to characterize the product, and
purity was determined using HPLC. After determining that
our product was refined, cytotoxicity testing in light and dark
conditions revealed that the novel H2TPP-2A2E, could
potentially be used in the next generation of photodynamic
therapy.

• A porphyrins’ usefulness is largely due to its
conjugated structure, light absorbing qualities,
and efficacy as photosensitizers.
• Various uses of porphyrins include gene
regulation, drug and iron metabolism, hormone
synthesis, electron transfer medium (conducting
polymers), oxygen transport medium
(hemoglobin), solar cell (convert light or chemical
energy), metal binder (ligand).
• This research specifically utilizes and tests the
light sensitivity of the porphyrins and how they
react to cells.
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• Correlation between higher concentrations
of 2A2E and compound toxicity.
2-Amino-2-ethyl-1,3-propanediol

H2TPPC

• MTT assay results indicate that the exposure
to light significantly decreases cell viability.
• The largest difference in cell viability is found
at a concentration of 250 uM, at which cells
kept in the dark maintained their original
viability compared to those exposed to light
which have 22% viability.

Figure 1: Standard Porphyrin Core Structure (Unsubstituted)
H2TPP-2A2E

A standard poryphrin ring structure,
unsubstituted.

Nuclear Magnetic Resonance Spectroscopy
Reaction 1
• 4-formylbenzoic acid (2) reacted with pyrrole (1) in a propionic
acid solution to form H2TPPC (3).

Figure 2: R-Group attached to Porphyrin Core

2-Amino-2-ethyl-1,3-propanediol
2-Amino-2-ethyl-1,3-propanedio

H2TPP-2A2E

High Performance Liquid Chromatography
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Reaction 2
• H2TPPC (3) reacts with thionyl chloride in dimethylformamide,
forming an acid chloride porphyrin (4).

Non-small Cell Lung Cancer Cells
The most common form of lung cancer
Constitutes 84% of all lung cancer diagnoses
5 year survival rate is 24%

Waters NovaPak C₁₈ 3.9 x 150 mm
Column
100% Acetonitrile Solvent
98% Purity

Photodynamic Therapy
•
•
•
•

A patient diagnosed with a tumor is injected with a
photosensitizer.
Due to the nature of the photosensitizer, it collects in
the tumor over time.
The tumor is exposed to light for a given amount of
time, activating the photosensitizer.
The tumor is selectively destroyed.

• A novel water-soluble porphyrin was
successfully synthesized.
• The compound was characterized by UV-vis, IR,
and NMR spectroscopies.
• The spectrums indicate that the correct
compound has indeed been formed.
• At concentrations of 100 uM and above, light
treatment consistently increases cell death,
whereas treated cells kept in the dark remained
viable.
• Results conclude that at high concentrations,
H2TPP-2A2E is an effective photosensitizer.

Reaction 3
• The acid chloride porphyrin (4) reacts with diisopropylamine in
methanol to form , the final product (5).

• Light (left) and dark (right)
• H2TPP-2A2E plated on wells
8-12

• Examine the cytotoxicity of H2TPP-2A2E
among normal cells and other cancer cell
lines.
• Synthesize additional novel water-soluble
metallic porphyrin derivatives, such as
ZnTPP-DIPA, to see if other derivatives are
more desirable in killing A549 lung cancer
cells and are, therefore, candidates for PDT.

• 50 uM, 100 uM, 150 uM,
200 uM, and 250 uM
concentrations
• Purple is indicative of living
cells.
• Column 12 of the light plate
are noticeably lighter in
color.
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